HRP20211765T1 - Kompozicija za sprječavanje opadanja kose i za pospješivanje rasta kose - Google Patents
Kompozicija za sprječavanje opadanja kose i za pospješivanje rasta kose Download PDFInfo
- Publication number
- HRP20211765T1 HRP20211765T1 HRP20211765TT HRP20211765T HRP20211765T1 HR P20211765 T1 HRP20211765 T1 HR P20211765T1 HR P20211765T T HRP20211765T T HR P20211765TT HR P20211765 T HRP20211765 T HR P20211765T HR P20211765 T1 HRP20211765 T1 HR P20211765T1
- Authority
- HR
- Croatia
- Prior art keywords
- phase
- solution
- finasteride
- minoxidil
- ethanol
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims 5
- 230000003779 hair growth Effects 0.000 title claims 4
- 201000004384 Alopecia Diseases 0.000 title 1
- 208000024963 hair loss Diseases 0.000 title 1
- 230000003676 hair loss Effects 0.000 title 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N EtOH Substances CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 8
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 claims 8
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims 8
- 229960004039 finasteride Drugs 0.000 claims 6
- 229960003632 minoxidil Drugs 0.000 claims 6
- 230000001476 alcoholic effect Effects 0.000 claims 5
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims 4
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 claims 4
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 claims 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims 4
- 229930003471 Vitamin B2 Natural products 0.000 claims 4
- 229960001948 caffeine Drugs 0.000 claims 4
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 claims 4
- DBEPLOCGEIEOCV-WSBQPABSSA-N finasteride Chemical compound N([C@@H]1CC2)C(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](C(=O)NC(C)(C)C)[C@@]2(C)CC1 DBEPLOCGEIEOCV-WSBQPABSSA-N 0.000 claims 4
- 238000004519 manufacturing process Methods 0.000 claims 4
- 238000000034 method Methods 0.000 claims 4
- 229960002477 riboflavin Drugs 0.000 claims 4
- 239000011716 vitamin B2 Substances 0.000 claims 4
- 235000019164 vitamin B2 Nutrition 0.000 claims 4
- 230000001737 promoting effect Effects 0.000 claims 3
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 238000003756 stirring Methods 0.000 claims 2
- 238000010438 heat treatment Methods 0.000 claims 1
- 230000003658 preventing hair loss Effects 0.000 claims 1
- 230000000284 resting effect Effects 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Emergency Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Claims (6)
1. Alkoholna otopina koja sadrži
- etanol,
- monopropilen glikol,
- minoksidil i
- finasterid
naznačena time, što otopina dodatno sadrži vitamin B2 i/ili dodatno sadrži kofein.
2. Otopina prema patentnom zahtjevu 1, naznačen time, što otopina sadrži
- 10 do 30 mas%, poželjno 15 do 30 mas% etanola,
- 60 - 85 mas%, poželjno 65 - 80 mas% monopropilen glikola,
- 2 do 7,5 mas%, poželjno 3 do 6 mas% minoksidila i
- 0,1 do 3 mas%, poželjno 0,1 do 2,7 mas% finasterida,
- 0,001 – 2 mas%, poželjno 0,001 do 0,5 mas% vitamina B2,
- 0,0005 do 2 mas% kofeina, u odnosu na ukupnu masu alkoholnog rastvora.
3. Otopina prema jednom od prethodnih patentnih zahtjeva, naznačen time, što otopina obuhvaća
10 do 30 mas%, poželjno 15 do 30 mas%, naročito poželjno 17 do 27 mas% etanola,
- 60 - 85 mas%, poželjno 65 - 80 mas%, naročito poželjno 65 do 75 mas% monopropilen glikola,
- 2 do 7,5 mas%, poželjno 3 do 6 mas% minoksidila i
- 0,1 do 3 mas%, poželjno 0,1 do 2,7 mas%, naročito poželjno 0,1 do 0,5 mas% finasterida,
- 0,001-2 mas% vitamina B2,
- 0,0005-2 mas% kofeina i
- 0-2 mas% Penisetum Glaucum-a.
pri čemu se komponente dopunjuju do 100 mas%.
4. Postupak za proizvodnju alkoholne otopine koja sadrži
- etanol,
- monopropilen glikol,
- finasterid,
- minoksidil,
koji obuhvaća korake
A. Proizvodnja prve faze u koracima postupka:
A.1. spremanje etanola,
A.2. dodavanje finasterida u otopinu prema A.1. i miješanje dok se finasterid ne otopi i dok se otopina potpuno ne razbistri (faza 1),
A.3. dodavanje 0,0005%-2% kofeina i miješanje dok se u potpunosti ne otopi,
A.4. dodavanje 0,001%-2% vitamina B2 i miješanje dok se u potpunosti ne otopi i
ovisno od slučaja A.5 mirovanje smjese iz koraka A.2, A.3 ili A.4,
B. Proizvodnja druge faze u koracima postupka:
B.1. spremanje monopropilen glikola u posudi,
B. 2. zagrijavanje smjese na temperature od 25 do 45 °C, poželjno 20 do 40 °C,
B.3. dodavanje minoksidila u otopinu i miješanje dok se minoksidil ne otopi (faza 2) i
ovisno od slučaja B.3. mirovanje smjese dobivene iz koraka B.3.
C. Proizvodnja konačne otopine u koracima postupka:
C.1. spremanje faze 1 ili faze 2, poželjno faze 1,
C.2. dodavanje faze 2 u fazu 1 ili faze 1 u fazu 2 i miješanje,
zavisno od slučaja C.3. mirovanje smjese dobivene iz koraka C.2.
5. Alkoholna otopina prema jednom od patentnih zahtjeva 1 do 3 za primjenu u svojstvu lokalnog sredstva za pospješivanje rasta kose za nanošenje na kožu.
6. Neterapijska primjena alkoholne otopine prema jednom od patentnih zahtjeva 1 do 3 u svojstvu lokalnog sredstva za pospješivanje rasta kose, naročito za sprječavanje opadanja kose i za pospješivanje rasta kose.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR201708931 | 2017-06-16 | ||
| EP18734120.1A EP3638198B1 (de) | 2017-06-16 | 2018-06-12 | Zusammensetzung zur verhinderung von haarausfall und wachstumsförderung von haaren |
| PCT/EP2018/065546 WO2018229072A1 (de) | 2017-06-16 | 2018-06-12 | Zusammensetzung zur verhinderung von haarausfall und wachstumsförderung von haaren |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20211765T1 true HRP20211765T1 (hr) | 2022-02-18 |
Family
ID=62748931
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20211765TT HRP20211765T1 (hr) | 2017-06-16 | 2018-06-12 | Kompozicija za sprječavanje opadanja kose i za pospješivanje rasta kose |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP3638198B1 (hr) |
| CY (1) | CY1125412T1 (hr) |
| DE (1) | DE212018000242U1 (hr) |
| DK (1) | DK3638198T3 (hr) |
| ES (1) | ES2898222T3 (hr) |
| HR (1) | HRP20211765T1 (hr) |
| HU (1) | HUE057207T2 (hr) |
| LT (1) | LT3638198T (hr) |
| PL (1) | PL3638198T3 (hr) |
| PT (1) | PT3638198T (hr) |
| RS (1) | RS62654B1 (hr) |
| SI (1) | SI3638198T1 (hr) |
| WO (1) | WO2018229072A1 (hr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK202170171A1 (en) | 2021-04-13 | 2022-10-19 | Cs Medica As | Hair serum and supplement |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW382595B (en) * | 1993-10-15 | 2000-02-21 | Merck & Co Inc | Pharmaceutical composition for use in arresting and reversing androgenic alopecia |
| WO2007101357A2 (de) * | 2006-03-07 | 2007-09-13 | Pelloni, Claudio | Haarwuchsmittel zur behandlung von menschlichen keratinfasern und verfahren zu dessen herstellung |
| DE102011089366A1 (de) * | 2011-12-21 | 2012-09-06 | Henkel Ag & Co. Kgaa | Haarwuchsmittel enthaltend Moringa Extrakt |
| BR102012022036B1 (pt) * | 2012-08-31 | 2019-10-01 | Biolab Sanus Farmacêutica Ltda. | Nanopartícula polimérica de finasterida e minoxidil, processo de sua preparação, suspensão aquosa contendo a mesma, composição farmacêutica, e seu uso |
-
2018
- 2018-06-12 EP EP18734120.1A patent/EP3638198B1/de active Active
- 2018-06-12 LT LTEPPCT/EP2018/065546T patent/LT3638198T/lt unknown
- 2018-06-12 DK DK18734120.1T patent/DK3638198T3/da active
- 2018-06-12 ES ES18734120T patent/ES2898222T3/es active Active
- 2018-06-12 PL PL18734120T patent/PL3638198T3/pl unknown
- 2018-06-12 WO PCT/EP2018/065546 patent/WO2018229072A1/de unknown
- 2018-06-12 SI SI201830459T patent/SI3638198T1/sl unknown
- 2018-06-12 PT PT187341201T patent/PT3638198T/pt unknown
- 2018-06-12 HR HRP20211765TT patent/HRP20211765T1/hr unknown
- 2018-06-12 DE DE212018000242.8U patent/DE212018000242U1/de active Active
- 2018-06-12 HU HUE18734120A patent/HUE057207T2/hu unknown
- 2018-06-12 RS RS20211376A patent/RS62654B1/sr unknown
-
2021
- 2021-11-11 CY CY20211100984T patent/CY1125412T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RS62654B1 (sr) | 2021-12-31 |
| PL3638198T3 (pl) | 2022-03-14 |
| PT3638198T (pt) | 2021-11-18 |
| EP3638198A1 (de) | 2020-04-22 |
| LT3638198T (lt) | 2021-12-10 |
| DK3638198T3 (da) | 2021-11-22 |
| SI3638198T1 (sl) | 2022-02-28 |
| ES2898222T3 (es) | 2022-03-04 |
| DE212018000242U1 (de) | 2020-02-06 |
| HUE057207T2 (hu) | 2022-04-28 |
| WO2018229072A1 (de) | 2018-12-20 |
| CY1125412T1 (el) | 2023-03-24 |
| EP3638198B1 (de) | 2021-08-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2019001160A1 (es) | 1,2,4–triazolonas 2,4,5–trisustituidas. | |
| CL2018000730A1 (es) | Compuestos heterocíclicos y usos de los mismos | |
| NI201700128A (es) | Composiciones de acido obeticolico y metodos de uso. | |
| CL2019002464A1 (es) | Formas cristalinas del derivado de 4-pirimidinsulfamida de aprocitentán. | |
| CL2016000188A1 (es) | Composiciones de arní de serpinc1 y métodos de uso de las mismas | |
| BR112016028942A2 (pt) | método para preparar uma composição estável com perfume | |
| MY178425A (en) | Anti-microbial composition | |
| MX2017004896A (es) | Uso de hexadeca-8, 15-dienal como producto quimico aromatico. | |
| MX2016013693A (es) | Crema transdermica. | |
| ES2820879R1 (es) | Composiciones para la liberación controlada de ingredientes activos y métodos de preparación de las mismas | |
| EP4043541C0 (en) | MECHANISM OF URIC ACID/SOLID ACID INTERACTION UNDER STORAGE CONDITIONS AND MANUFACTURING METHODS FOR STORAGE-STABLE SOLID COMPOSITIONS CONTAINING UREA AND ACID | |
| PH12018500374A1 (en) | Antimicrobial compositions and formulations releasing hydrogen peroxide | |
| MX2019007028A (es) | Metodo para acondicionar el cabello. | |
| BR112017028300A2 (pt) | composição nutricional, creme de café, métodos para fabricação de caseína micelar e para preparação uma composição nutricional | |
| BR112018071831A2 (pt) | composições anti-irritantes sinérgicas de taurina e aloé e métodos | |
| CL2018000363A1 (es) | Derivados del ácido 5-(n-bencil-tetrahidroisoquinolin-6-il)-piridin-3-il acético como inhibidores de la replicación del virus de la inmunodeficiencia humana. | |
| WO2015171460A3 (en) | Formulations of cyclophosphamide liquid concentrate | |
| HRP20211765T1 (hr) | Kompozicija za sprječavanje opadanja kose i za pospješivanje rasta kose | |
| PH12016501459B1 (en) | Stable herbicidal compositions | |
| MX2020010834A (es) | Formulacion solida de mezclas insecticidas. | |
| MX2020000873A (es) | Derivados de ácidos biliares marcados isotópicamente. | |
| ECSP19026563A (es) | Derivados sustituidos de 6-(1h-pirazol-1-il)pirimidin-4-amina y usos de los mismos | |
| BR112018013014A2 (pt) | composições de higiene pessoal | |
| MX2018003642A (es) | Espuma quimica sin enjuage que contiene propionato de clobetasol y su uso en el tratamiento de la psoriasis. | |
| IL262494A (en) | A pharmaceutical combination preparation containing Ivacaptor and Lomaceptor complex compositions, their salts and derivatives, a process for their preparation and pharmaceutical preparations containing them |